Jove
Visualize
Contact Us

Related Experiment Videos

Labeling peptides with rhenium-188.

L Meléndez-Alafort1, G Ferro-Flores, C Arteaga-Murphy

  • 1Instituto Nacional de Nutrición, Salvador Zubirán, Mexico.

International Journal of Pharmaceutics
|May 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preliminary dosimetric analysis of DOTA-folate radiopharmaceutical radiolabelled with <sup>47</sup>Sc produced through <sup>nat</sup>V(p,x)<sup>47</sup>Sc cyclotron irradiation.

Physics in medicine and biology·2021
Same author

Synthesis and Biochemical Evaluation of Samarium-153 Oxide Nanoparticles Functionalized with iPSMA-Bombesin Heterodimeric Peptide.

Journal of biomedical nanotechnology·2020
Same author

Synthesis, chemical and biochemical characterization of Lu<sub>2</sub>O<sub>3</sub>-iPSMA nanoparticles activated by neutron irradiation.

Materials science & engineering. C, Materials for biological applications·2020
Same author

Radioisotopic purity and imaging properties of cyclotron-produced <sup>99m</sup>Tc using direct <sup>100</sup>Mo(p,2n) reaction.

Physics in medicine and biology·2018
Same author

Dosimetric properties of KMgF<sub>3</sub>:Tb + PTFE.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2018
Same author

Monte Carlo calculations of the cellular S-values for α-particle-emitting radionuclides incorporated into the nuclei of cancer cells of the MDA-MB231, MCF7 and PC3 lines.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

A new method for preparing rhenium-188 (188Re)-labeled somatostatin analogue peptides was developed. This technique achieves high radiochemical purity and specific activity, crucial for effective radiopharmaceutical applications.

Area of Science:

  • Nuclear medicine
  • Radiopharmaceutical chemistry
  • Peptide chemistry

Background:

  • Somatostatin analogues are vital in diagnosing and treating neuroendocrine tumors.
  • Efficient radiolabeling methods are essential for developing targeted radiopharmaceuticals.
  • Rhenium-188 (188Re) offers advantageous properties for therapeutic and diagnostic applications.

Purpose of the Study:

  • To develop a direct labeling technique for a 188Re-somatostatin analogue peptide.
  • To optimize reaction conditions for efficient radiolabeling.
  • To establish analytical methods for quality control of the radiopharmaceutical.

Main Methods:

  • Direct labeling using ethane-1-hydroxy-1,1-diphosphonate (EHDP) as a chelator.
  • Investigation of reaction parameters: pH, temperature, ligand concentration, and stannous chloride concentration.

Related Experiment Videos

  • Development of analytical techniques for purity and identity assessment.

    • Main Results:

    • Successful preparation of the 188Re-peptide complex.
    • Optimized conditions yielded a radiochemical purity of 90%.
    • Achieved a specific activity of up to 1.8 GBq mg-1.
    • Demonstrated stability against radiolytic degradation.

    Conclusions:

    • A robust direct labeling method for 188Re-somatostatin analogue peptide was established.
    • The developed method provides high yield and purity suitable for clinical use.
    • This technique facilitates the development of targeted 188Re-based radiopharmaceuticals.